ResMed (RMD) Tops Q1 EPS by 15c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $220.37 --0%
Financial Fact:
Income from operations: 94.15M
Today's EPS Names:
SYRS, EGRX, AIFC, More
Financial Fact:
Income from operations: 94.15M
Today's EPS Names:
SYRS, EGRX, AIFC, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q1 EPS of $1.51, $0.15 better than the analyst estimate of $1.36. Revenue for the quarter came in at $904 million versus the consensus estimate of $860.89 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Resmed Announces Appointment of Carol Burt as Lead Director and Planned Retirement of Director Ron Taylor
- Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance
- VNET Group (VNET) Misses Q2 EPS by 164c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
